Diabetic Retinopathy

Diabetic Retinopathy (DR) stands as one of the most prevalent and debilitating complications of diabetes mellitus, posing a significant global public health burden. This specialized conference track aims to convene ophthalmologists, researchers, clinicians, and industry experts to explore the latest advancements, challenges, and innovations in the field of DR.

Key Themes and Topics:

1. Epidemiology and Pathogenesis: Review the epidemiological trends and risk factors associated with diabetic retinopathy, including duration of diabetes, glycemic control, hypertension, and hyperlipidemia. Explore the underlying pathophysiological mechanisms driving the development and progression of DR.
2. Screening and Diagnostic Strategies: Discuss the role of screening programs and diagnostic modalities, such as fundus photography, optical coherence tomography (OCT), and fluorescein angiography (FA), in early detection and monitoring of diabetic retinopathy.
3. Classification and Staging: Review the various classification systems and staging criteria for diabetic retinopathy, including the Early Treatment Diabetic Retinopathy Study (ETDRS) classification, and their clinical significance in guiding treatment decisions and prognosis.
4. Management Approaches: Evaluate the current treatment modalities for diabetic retinopathy, including laser photocoagulation, intravitreal pharmacotherapy (anti-VEGF agents, corticosteroids), and surgical interventions (vitrectomy), and their respective indications, efficacy, and safety profiles.
5. Diabetic Macular Edema (DME): Explore the pathogenesis, diagnosis, and treatment options for diabetic macular edema, a sight-threatening complication of diabetic retinopathy, including intravitreal anti-VEGF therapy, corticosteroids, and sustained-release drug delivery systems.